Dwarfbodies
Therapeutics Dwarfbody-Therapeutics
treatment target of Dwarfbody
DB-Tx
sound company portfolio
ineffective treatment
Pancreatic cancer
new company
aggressive cancer types
sound business plan
initial target market
co-administering
test Trial Centers
safe low molecular weight antibodies
Gastro-Intestinal Cancers
reports
frontrunner research team
concept
production
current
anticancer effects
investments
competing molecules
various high ranked journals
AMC Amsterdam
supportive grants
additional proof
partnerships
spin
basis
attractive licencing deals
development
therapeutic outcome
PANTREAT
Results
superiority